Europe
Clinical data showed Dupixent reduces nasal polyp size, improves congestion and loss of smell, while reducing the need for surgery and systemic corticosteroids.
Pharnext SA announced the appointment of Peter Collum as Chief Financial Officer and Chief Business Officer.
Evotec SE announced that the Company successfully issued a Schuldschein of EUR 250 m on the capital market.
The Rotterdam headquartered diagnostics company has been granted CAP accreditation, following its CLIA certification in December 2018 and became the first Dutch scale-up with a CAP and CLIA certified clinical laboratory in San Diego, joining an elite group of globally recognized facilities that operate at the highest level of quality laboratory standards.
Medidata announced that global pharmaceutical company Orion will consolidate all clinical trials on the Medidata Rave Clinical Cloud™ and expand its use of trial management solutions to support growth of its R&D pipeline.
NOXXON Pharma N.V. hereby announces the launch and terms of a share capital increase with shareholders’ preferential rights for an amount of up to € 3.9 million.
Biotech and pharma companies from across the globe share pipeline and business updates.
Humira generates about 60% of AbbVie’s annual revenue but is expected to lose patent protection in 2023.
Atomwise invented a deep learning artificial intelligence technology for structure-based small molecule drug discovery. Enamine is the world’s largest chemical supplier.
The Management Board of MagForce AG has resolved and successfully completed, with the approval of the Supervisory Board, on basis of the authorization provided for in the Company’s articles of association, an increase of the registerd share capital of the Company from currently EUR 26,463,802.00 to EUR 27,640,274.00 by issuing 1,176,472 new no-par value bearer shares under exclusion of the shareholders’ statutory subscription rights.
PRESS RELEASES